SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans 
U.S. Greenlights Nvidia H200 Chip Exports to China With 25% Fee 
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag 
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs 
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies 
Trump Criticizes EU’s €120 Million Fine on Elon Musk’s X Platform 
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute 
SK Hynix Shares Surge on Hopes for Upcoming ADR Issuance 
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO 
US Charges Two Men in Alleged Nvidia Chip Smuggling Scheme to China 
SoftBank Eyes Switch Inc as It Pushes Deeper Into AI Data Center Expansion 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
IBM Nears $11 Billion Deal to Acquire Confluent in Major AI and Data Push 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
Australia’s Under-16 Social Media Ban Sparks Global Debate and Early Challenges 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Alphabet Inc. is preparing to separate its life sciences subsidiary, Verily, in what could lead to a full sale or spinoff, according to recent testimony in a federal antitrust trial against Google. The move, revealed in court by Heather Adkins, Google’s Vice President of Security Engineering, marks the first public confirmation that Alphabet intends to divest Verily from its corporate structure.
Speaking in a Virginia courtroom, Adkins explained that Verily has been transitioning its operations from Google’s internal infrastructure to Google Cloud Platform for more than two years. This effort aims to make Verily technologically independent, a crucial step for any potential sale or spinoff. “We are in the process of helping them become an independent company,” Adkins stated. “The idea is to have it no longer be an Alphabet entity.”
Verily, launched as part of Alphabet’s push into health sciences, focuses on developing digital health solutions, data-driven research tools, and technologies that improve patient care. While Alphabet has previously worked to reduce Verily’s reliance on Google systems, Thursday’s testimony represents the clearest signal yet that Alphabet is preparing to cut ties with the unit.
The separation comes as Alphabet faces increased scrutiny over its dominance in digital advertising. The Justice Department’s case against Google centers on alleged monopolistic practices, and Adkins’ testimony offered a rare glimpse into Alphabet’s broader restructuring plans.
If Verily is spun off or sold, the move could reshape Alphabet’s portfolio by narrowing its focus on core businesses such as Google Search, YouTube, and cloud services, while positioning Verily to attract independent investors and partnerships in the rapidly growing health technology sector.
The potential spinoff underscores Alphabet’s evolving strategy of streamlining its business while allowing innovative subsidiaries like Verily to pursue independent growth paths in competitive industries.
